Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma (Q43850811)

27 November 2017

Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma (English)

1 reference

27 November 2017

1 reference

Giuseppe Aprile

1

1 reference

27 November 2017

Claudio Avellini

2

1 reference

27 November 2017

Michele Reni

3

1 reference

27 November 2017

Micol Mazzer

4

1 reference

27 November 2017

Luisa Foltran

5

1 reference

27 November 2017

Diego Rossi

6

1 reference

27 November 2017

Stefano Cereda

7

1 reference

27 November 2017

Emiliana Iaiza

8

1 reference

27 November 2017

Gianpiero Fasola

9

1 reference

27 November 2017

Andrea Piga

10

1 reference

27 November 2017

language of work or name

1 reference

25 September 2012

1 reference

27 November 2017

1 reference

27 November 2017

34

1 reference

27 November 2017

1

1 reference

27 November 2017

131-137

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-012-0520-2

27 November 2017

0 references

cites work

Tumor-stroma interactions

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

The role of the tumor microenvironment in the progression of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Butyrate inhibits pancreatic cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Molecular prognostic markers in pancreatic cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Pancreatic tumor cells influence the composition of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Basement membrane proteins play an important role in the invasive processes of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Basics of TGF-beta and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Cell intrinsic role of COX-2 in pancreatic cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Importance of performance status for treatment outcome in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Analysis of long-term survivors after surgical resection for pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Tumor-node-metastasis staging of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Predicting survival after surgical resection for pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Survival and prognostic factors of unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Prognostic factors for long-term survival in patients with locally invasive pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Molecular prognostic factors in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Clinical significance of midkine expression in pancreatic head carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Clinical significance of focal adhesion kinase in resectable pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Cyclin E Expression and Outcome in Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0520-2

Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer

21 January 2018

1 reference

12 December 2020

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

1 reference

12 December 2020

The European organization for research and treatment of cancer quality of life questionnaire: implications for prognosis in pancreatic cancer

1 reference

12 December 2020

Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases

1 reference

12 December 2020

Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis

1 reference

12 December 2020

Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

1 reference

12 December 2020

Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis

1 reference

12 December 2020

Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma

1 reference

12 December 2020

The role of cell adhesion molecule in cancer progression and its application in cancer therapy.

1 reference

12 December 2020

Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer

1 reference

12 December 2020

Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers

1 reference

12 December 2020

Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas

1 reference

12 December 2020

10.1007/S13277-012-0520-2

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference